The Latin America, Middle East and Africa Dental Bone Grafts And Substitutes Market should witness market growth of 10.5% CAGR during the forecast period (2022-2028).
A bone replacement called a xenograft is made of deproteinized bone marrow and has a highly porous hydroxyapatite structure that is comparable to the cortical bone of the human species. The organic component is heated and processed chemically.
These grafts contain a pore system with particles that range in size from 0.25 to 1 mm, which allows blood vessels to readily infiltrate them and cause osteoblastic migration because of the structure's extensive interconnectivity.
Some grafts may be processed using a high temperature, while others may be processed using a moderate temperature. It is said to be the most physiological transplant because xenogenous transplant administered at low temperature (300oC) after post-transplantation will be fully incorporated into human bone tissue.
One of the key drivers of economic expansion in the United Arab Emirates (UAE) is the healthcare sector. Due to escalating healthcare prices and the absence of insurance coverage for particular treatments like dermatology, dentistry, and orthopedics in western nations, the UAE has become a popular choice for westerners seeking medical care. The Dubai World Trade Center reports that around 350, 118 tourists traveled to the area in 2019 for medical purposes.
The Brazil market dominated the LAMEA Dental Bone Grafts and Substitutes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $19.8 million by 2028.The Argentina market is exhibiting a CAGR of 11.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 10.2% during (2022-2028).
Based on End-use, the market is segmented into Dental Clinics and Hospitals. Based on Material Type, the market is segmented into Xenograft, Allograft, Autograft and Synthetic. Based on Application, the market is segmented into Socket Preservation, Ridge Augmentation, Implant Bone Regeneration, Periodontal Defect Regeneration and Sinus Lift. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., Stryker Corporation, Institut Straumann AG, BioHorizons, Inc. (Henry Schein, Inc.), RTI Surgical, Inc., Geistlich Pharma AG (The Geistlich Group), Collagen Matrix, Inc. (Linden Capital Partners), and Dentium Co., Ltd.
A bone replacement called a xenograft is made of deproteinized bone marrow and has a highly porous hydroxyapatite structure that is comparable to the cortical bone of the human species. The organic component is heated and processed chemically.
These grafts contain a pore system with particles that range in size from 0.25 to 1 mm, which allows blood vessels to readily infiltrate them and cause osteoblastic migration because of the structure's extensive interconnectivity.
Some grafts may be processed using a high temperature, while others may be processed using a moderate temperature. It is said to be the most physiological transplant because xenogenous transplant administered at low temperature (300oC) after post-transplantation will be fully incorporated into human bone tissue.
One of the key drivers of economic expansion in the United Arab Emirates (UAE) is the healthcare sector. Due to escalating healthcare prices and the absence of insurance coverage for particular treatments like dermatology, dentistry, and orthopedics in western nations, the UAE has become a popular choice for westerners seeking medical care. The Dubai World Trade Center reports that around 350, 118 tourists traveled to the area in 2019 for medical purposes.
The Brazil market dominated the LAMEA Dental Bone Grafts and Substitutes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $19.8 million by 2028.The Argentina market is exhibiting a CAGR of 11.1% during (2022-2028). Additionally, The UAE market would display a CAGR of 10.2% during (2022-2028).
Based on End-use, the market is segmented into Dental Clinics and Hospitals. Based on Material Type, the market is segmented into Xenograft, Allograft, Autograft and Synthetic. Based on Application, the market is segmented into Socket Preservation, Ridge Augmentation, Implant Bone Regeneration, Periodontal Defect Regeneration and Sinus Lift. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., Stryker Corporation, Institut Straumann AG, BioHorizons, Inc. (Henry Schein, Inc.), RTI Surgical, Inc., Geistlich Pharma AG (The Geistlich Group), Collagen Matrix, Inc. (Linden Capital Partners), and Dentium Co., Ltd.
Scope of the Study
By End-use
- Dental Clinics
- Hospitals
By Material Type
- Xenograft
- Allograft
- Autograft
- Synthetic
By Application
- Socket Preservation
- Ridge Augmentation
- Implant Bone Regeneration
- Periodontal Defect Regeneration
- Sinus Lift
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Zimmer Biomet Holdings, Inc.
- Dentsply Sirona, Inc.
- Stryker Corporation
- Institut Straumann AG
- BioHorizons, Inc. (Henry Schein, Inc.)
- RTI Surgical, Inc.
- Geistlich Pharma AG (The Geistlich Group)
- Collagen Matrix, Inc. (Linden Capital Partners)
- Dentium Co., Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Dental Bone Grafts and Substitutes Market, by End-use
1.4.2 LAMEA Dental Bone Grafts and Substitutes Market, by Material Type
1.4.3 LAMEA Dental Bone Grafts and Substitutes Market, by Application
1.4.4 LAMEA Dental Bone Grafts and Substitutes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Dental Bone Grafts and Substitutes Market by End-use
3.1 LAMEA Dental Clinics Market by Country
3.2 LAMEA Hospitals Market by Country
Chapter 4. LAMEA Dental Bone Grafts and Substitutes Market by Material Type
4.1 LAMEA Xenograft Market by Country
4.2 LAMEA Allograft Market by Country
4.3 LAMEA Autograft Market by Country
4.4 LAMEA Synthetic Market by Country
Chapter 5. LAMEA Dental Bone Grafts and Substitutes Market by Application
5.1 LAMEA Socket Preservation Market by Country
5.2 LAMEA Ridge Augmentation Market by Country
5.3 LAMEA Implant Bone Regeneration Market by Country
5.4 LAMEA Periodontal Defect Regeneration Market by Country
5.5 LAMEA Sinus Lift Market by Country
Chapter 6. LAMEA Dental Bone Grafts and Substitutes Market by Country
6.1 Brazil Dental Bone Grafts and Substitutes Market
6.1.1 Brazil Dental Bone Grafts and Substitutes Market by End-use
6.1.2 Brazil Dental Bone Grafts and Substitutes Market by Material Type
6.1.3 Brazil Dental Bone Grafts and Substitutes Market by Application
6.2 Argentina Dental Bone Grafts and Substitutes Market
6.2.1 Argentina Dental Bone Grafts and Substitutes Market by End-use
6.2.2 Argentina Dental Bone Grafts and Substitutes Market by Material Type
6.2.3 Argentina Dental Bone Grafts and Substitutes Market by Application
6.3 UAE Dental Bone Grafts and Substitutes Market
6.3.1 UAE Dental Bone Grafts and Substitutes Market by End-use
6.3.2 UAE Dental Bone Grafts and Substitutes Market by Material Type
6.3.3 UAE Dental Bone Grafts and Substitutes Market by Application
6.4 Saudi Arabia Dental Bone Grafts and Substitutes Market
6.4.1 Saudi Arabia Dental Bone Grafts and Substitutes Market by End-use
6.4.2 Saudi Arabia Dental Bone Grafts and Substitutes Market by Material Type
6.4.3 Saudi Arabia Dental Bone Grafts and Substitutes Market by Application
6.5 South Africa Dental Bone Grafts and Substitutes Market
6.5.1 South Africa Dental Bone Grafts and Substitutes Market by End-use
6.5.2 South Africa Dental Bone Grafts and Substitutes Market by Material Type
6.5.3 South Africa Dental Bone Grafts and Substitutes Market by Application
6.6 Nigeria Dental Bone Grafts and Substitutes Market
6.6.1 Nigeria Dental Bone Grafts and Substitutes Market by End-use
6.6.2 Nigeria Dental Bone Grafts and Substitutes Market by Material Type
6.6.3 Nigeria Dental Bone Grafts and Substitutes Market by Application
6.7 Rest of LAMEA Dental Bone Grafts and Substitutes Market
6.7.1 Rest of LAMEA Dental Bone Grafts and Substitutes Market by End-use
6.7.2 Rest of LAMEA Dental Bone Grafts and Substitutes Market by Material Type
6.7.3 Rest of LAMEA Dental Bone Grafts and Substitutes Market by Application
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Zimmer Biomet Holdings, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations and Agreements:
7.3 Dentsply Sirona, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent Strategies and Development:
7.3.5.1 Product launches and Product Expansions:
7.4 Stryker Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Institut Straumann AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.6 BioHorizons, Inc. (Henry Schein, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 RTI Surgical, Inc.
7.7.1 Company Overview
7.8 Geistlich Pharma AG (The Geistlich Group)
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Acquisition and Mergers:
7.9 Collagen Matrix, Inc. (Linden Capital Partners)
7.9.1 Company Overview
7.10. Dentium Co., Ltd
7.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Zimmer Biomet Holdings, Inc.
- Dentsply Sirona, Inc.
- Stryker Corporation
- Institut Straumann AG
- BioHorizons, Inc. (Henry Schein, Inc.)
- RTI Surgical, Inc.
- Geistlich Pharma AG (The Geistlich Group)
- Collagen Matrix, Inc. (Linden Capital Partners)
- Dentium Co., Ltd.
Methodology
LOADING...
